Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 21, 2026
Clonal Hematopoiesis Rates in a Recurrent Venous Thrombosis Population: A Prospective Pilot StudyTamanna Haque, Arletta Lozanski, Tzy-Jyye Doong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2017
Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of IbrutinibCameron J Turtle, Kevin A Hay, Laïla-Aïcha Hanafi, et al.
Leukemia & Lymphoma|February 29, 2012
Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B studyGerard Lozanski, Amy S Ruppert, Nyla A Heerema, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemiaVeronica Balatti, Lara Rizzotto, Cecelia Miller, et al.
JCI Insight|June 20, 2020
LC-FACSeq is a method for detecting rare clones in leukemiaEileen Y Hu, James S Blachly, Caner Saygin, et al.
Blood|May 15, 2015
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activationTa-Ming Liu, Jennifer A Woyach, Yiming Zhong, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
MYD88 mutations in clonal hematopoiesis promote inflammation and hematopoietic stem cell expansionJennifer Yeung, Sophia Y Philbrook, Emma Uible, et al.
American Journal of Hematology|January 23, 2016
De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohortLapo Alinari, Alejandro Gru, Carl Quinion, et al.
Plos One|October 17, 2013
Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to diseaseErin Hertlein, Kyle A Beckwith, Gerard Lozanski, et al.
Cell Reports|July 20, 2022
Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivityChi-Ling Chiang, Eileen Y Hu, Lingqian Chang, et al.
Pageof 2